Lab
Vitro Molecular Laboratories
Vitro Molecular Laboratories was paid $19K by Medicaid between Sep 2019 and Oct 2024, across 5 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 79% of everything it billed.
33Billing provider infoVITRO MOLECULAR LABORATORIES
MIAMI, FL 33174
MIAMI, FL 33174
33aNPI1881780138assigned 10/05/2006
33bProvider typeClinical Medical Laboratory
28Total paid$19K
24GClaims889
24DCodes billed5
24AFirst – last monthSep 2019 – Oct 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Florida
Rank by total paid#137 of 225
Median peer was paid$74K
This provider vs. median0.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 42 | $1K | |
| 2020 | 377 | $8K | |
| 2021 | 301 | $7K | |
| 2022 | 92 | $2K | |
| 2023 | 58 | $561.94 | |
| 2024incomplete | 19 | $809.38 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 79% | 779 | 307 | $15K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 11% | 30 | 28 | $2K |
| 88342 | 5.8% | 38 | 34 | $1K | |
| 88341 | 3.8% | 14 | 12 | $721.32 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 28 | 27 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialYAZIJI, HADI (MEDICAL DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Nextgen Pathology | Rockledge, FL | $626K |
| Nextgen Pathology | Melbourne, FL | $72K |
| Ancillary Pathways, LLC | Miami, FL | $62K |
| Nextgen Pathology | Palm Bay, FL | $25K |
| Nextgen Pathology | Cocoa Beach, FL | $12K |
| Nextgen Pathology | Viera, FL | $8K |
| Nextgen Pathology | Melbourne, FL | $4K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.